Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-27 Sale |
2024-03-27 8:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
5,140 | $17.9 | $92,006 | 153,316 (Direct) |
View |
| 2024-03-27 Sale |
2024-03-27 7:58 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
17,714 | $17.9 | $317,081 | 405,293 (Direct) |
View |
| 2024-03-27 Sale |
2024-03-27 7:57 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
5,434 | $17.9 | $97,269 | 131,461 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 6:13 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
772 | $24.67 | $19,045 | 22,420 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 6:10 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
624 | $24.67 | $15,394 | 32,539 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 6:07 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
474 | $24.67 | $11,694 | 12,231 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 6:02 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
5,577 | $24.67 | $137,585 | 112,836 (Direct) |
View |
| 2024-01-08 Sale |
2024-01-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
3,732 | $29.96 | $111,811 | 96,521 (Direct) |
View |
| 2024-01-08 Sale |
2024-01-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
731 | $29.96 | $21,901 | 30,949 (Direct) |
View |
| 2024-01-08 Sale |
2024-01-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
590 | $29.96 | $17,676 | 46,901 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-15 7:37 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
2,000 | $28.3 | $56,600 | 11,025 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
4,960 | $22.64 | $112,294 | 70,045 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
5,108 | $22.64 | $115,645 | 60,138 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
1,985 | $22.64 | $44,940 | 28,887 (Direct) |
View |
| 2023-10-06 Sale |
2023-10-06 10:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
16,369 | $21.96 | $359,463 | 106,146 (Direct) |
View |
| 2023-10-06 Sale |
2023-10-06 9:59 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
51,563 | $21.96 | $1,132,323 | 262,463 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-19 6:31 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
2,000 | $25.88 | $51,760 | 10,778 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 7:31 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
10,000 | $29 | $289,970 | 15,682 (Direct) |
View |
| 2023-07-14 Sale |
2023-07-18 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
100,000 | $30.04 | $3,004,350 | 256,695 (Direct) |
View |
| 2023-07-11 Sale |
2023-07-13 8:27 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
71,602 | $25.04 | $1,792,899 | 36,695 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 4:38 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
2,000 | $24.15 | $48,300 | 9,144 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 5:14 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
4,500 | $24.87 | $111,906 | 13,502 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 8:48 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
974 | $25.02 | $24,369 | 24,717 (Direct) |
View |
| 2023-05-22 Purchase |
2023-05-24 5:09 pm |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
896,522 | $25.33 | $22,707,098 | 39,523,425 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:54 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
5,947 | $22.5 | $133,808 | 30,970 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:48 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
15,310 | $22.5 | $344,475 | 71,469 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 6:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
14,869 | $22.5 | $334,553 | 73,920 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-25 Option Award |
2024-03-27 8:00 pm |
N/A 2034-03-24 |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
127,024 | $0 | 153,316 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 7:58 pm |
N/A 2034-03-24 |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
321,117 | $0 | 405,293 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 7:57 pm |
N/A 2034-03-24 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
115,828 | $0 | 131,461 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 6:13 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
1,353 | $0 | 22,420 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 6:10 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
1,107 | $0 | 32,539 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 6:07 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
840 | $0 | 12,231 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 6:02 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
10,946 | $0 | 112,836 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 5:09 pm |
N/A 2034-02-05 |
ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC |
152,478 | $0 | 152,478 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
9,528 | $0 | 96,521 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
1,287 | $0 | 30,949 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
1,634 | $0 | 46,901 (Direct) |
View |
| 2023-11-24 Gift |
2023-11-28 5:32 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
2,918 | $0 | 15,862 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
9,912 | $0 | 70,045 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
9,912 | $0 | 60,138 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
3,964 | $0 | 28,887 (Direct) |
View |
| 2023-10-12 Exercise |
2023-10-16 5:30 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
4,381 | $0 | 8,762 (Direct) |
View |
| 2023-10-05 Exercise |
2023-10-06 10:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
36,174 | $0 | 106,146 (Direct) |
View |
| 2023-10-06 Exercise |
2023-10-06 9:59 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
207,998 | $0 | 262,463 (Direct) |
View |
| 2023-07-14 Exercise |
2023-07-18 6:00 pm |
N/A 2024-07-14 |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
100,000 | $0 | 256,695 (Direct) |
View |
| 2023-07-14 Exercise |
2023-07-18 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
100,000 | $20.77 | 256,695 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-12 8:48 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,893 | $0 | 24,717 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:46 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director |
18,002 | $0 | 45,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:46 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director |
17,697 | $0 | 45,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:43 pm |
N/A 2033-06-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
17,697 | $0 | 17,697 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:42 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
18,002 | $0 | 35,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:42 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
17,697 | $0 | 35,699 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:39 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
18,002 | $0 | 36,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:39 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
17,697 | $0 | 36,699 (Direct) |
View |
| 2021-06-22 Exercise |
2023-06-05 9:38 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
18,002 | $0 | 35,699 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:38 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
17,697 | $0 | 35,699 (Direct) |
View |
| 2022-06-07 Exercise |
2023-06-05 9:34 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
16,862 | $0 | 36,477 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 9:34 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
17,697 | $0 | 36,477 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:14 pm |
N/A 2033-05-31 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
35,394 | $0 | 39,558,819 (Indirect) |
View |
| 2023-05-23 Exercise |
2023-05-24 5:09 pm |
N/A 2023-06-07 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
25,000 | $0 | 39,523,425 (Indirect) |
View |
| 2023-05-23 Exercise |
2023-05-24 5:09 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
12,500 | $17.01 | 39,523,425 (Indirect) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:54 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
11,894 | $0 | 30,970 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:48 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
29,738 | $0 | 71,469 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 6:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
29,738 | $0 | 73,920 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:17 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
117,195 | $0 | 117,195 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 9:16 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
385,067 | $0 | 385,067 (Direct) |
View |